These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2888632)
1. Disposition of nafimidone in rats. Graham DJ; Hama KM; Smith SA; Kurz L; Chaplin MD; Hall DJ Drug Metab Dispos; 1987; 15(4):565-70. PubMed ID: 2888632 [TBL] [Abstract][Full Text] [Related]
2. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol. Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633 [TBL] [Abstract][Full Text] [Related]
3. The metabolism of nafimidone hydrochloride in the dog, primates and man. Rush WR; Alexander OF; Hall DJ; Dow RJ; Tokes L; Kurz L; Graham DJ Xenobiotica; 1990 Jan; 20(1):123-32. PubMed ID: 2109431 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog. Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917 [TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
6. Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine. Kapetanovic IM; Kupferberg HJ Drug Metab Dispos; 1984; 12(5):560-4. PubMed ID: 6149905 [TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo. Ono C; Yamada M; Tanaka M J Pharm Pharmacol; 2003 Dec; 55(12):1647-54. PubMed ID: 14738591 [TBL] [Abstract][Full Text] [Related]
8. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat. Garrigou-Gadenne D; Durand A; Thenot JP; Morselli PL Drug Metab Dispos; 1991; 19(3):574-9. PubMed ID: 1680622 [TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of [14C]-haloperidol in rats. Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663 [TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
11. Metabolism and disposition of moxonidine in Fischer 344 rats. He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314 [TBL] [Abstract][Full Text] [Related]
12. Metabolism, disposition, and pharmacokinetics of a potent anticonvulsant, 4-amino-N-(2,6-dimethylphenyl)benzamide (LY201116), in rats. Potts BD; Gabriel S; Parli CJ Drug Metab Dispos; 1989; 17(6):656-61. PubMed ID: 2575503 [TBL] [Abstract][Full Text] [Related]
13. Absorption, distribution and excretion of [14C]-Lesopitron after single and repeated administration in rats and dogs. Serafini MT; Puig S; García-Encina G; Farran R; García-Soret A; Moragon T; Martínez L Methods Find Exp Clin Pharmacol; 1997; 19(1):61-72. PubMed ID: 9098842 [TBL] [Abstract][Full Text] [Related]
14. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
16. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
17. Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration. Mathews JM; deCosta K; Thomas BF Drug Metab Dispos; 1996 Jul; 24(7):702-10. PubMed ID: 8818565 [TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution and excretion of 14C-levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin-related radioactivity to melanin in vivo. Tanaka M; Ono C; Yamada M J Pharm Pharmacol; 2004 Apr; 56(4):463-9. PubMed ID: 15099441 [TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]